- Home
- CRBU vs CYBN Comparison
CRBU vs CYBN Comparison
Compare CRBU & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- CYBN
- Stock Information
- Founded
- CRBU 2011
- CYBN 2019
- Country
- CRBU United States
- CYBN Canada
- Employees
- CRBU N/A
- CYBN N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- CYBN Pharmaceuticals and Biotechnology
- Sector
- CRBU Health Care
- CYBN Health Care
- Exchange
- CRBU Nasdaq
- CYBN Nasdaq
- Market Cap
- CRBU 151.2M
- CYBN 177.9M
- IPO Year
- CRBU 2021
- CYBN N/A
- Fundamental
- Price
- CRBU $1.31
- CYBN $9.09
- Analyst Decision
- CRBU Strong Buy
- CYBN Strong Buy
- Analyst Count
- CRBU 5
- CYBN 3
- Target Price
- CRBU $11.80
- CYBN $111.50
- AVG Volume (30 Days)
- CRBU 1.3M
- CYBN 350.4K
- Earning Date
- CRBU 03-10-2025
- CYBN 02-28-2025
- Dividend Yield
- CRBU N/A
- CYBN N/A
- EPS Growth
- CRBU N/A
- CYBN N/A
- EPS
- CRBU N/A
- CYBN N/A
- Revenue
- CRBU $11,475,000.00
- CYBN N/A
- Revenue This Year
- CRBU N/A
- CYBN N/A
- Revenue Next Year
- CRBU N/A
- CYBN N/A
- P/E Ratio
- CRBU N/A
- CYBN N/A
- Revenue Growth
- CRBU N/A
- CYBN N/A
- 52 Week Low
- CRBU $1.22
- CYBN $6.50
- 52 Week High
- CRBU $8.33
- CYBN $19.84
- Technical
- Relative Strength Index (RSI)
- CRBU 39.05
- CYBN 41.61
- Support Level
- CRBU $1.30
- CYBN $9.08
- Resistance Level
- CRBU $1.46
- CYBN $10.59
- Average True Range (ATR)
- CRBU 0.09
- CYBN 0.67
- MACD
- CRBU 0.02
- CYBN -0.04
- Stochastic Oscillator
- CRBU 33.33
- CYBN 13.76
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.